NEW YORK (Reuters Health) – Extended lymphadenectomy independently predicts improved survival following induction neoadjuvant chemoradiation (CRT) in patients with esophageal
Extent of Lymphadenectomy Predicts Survival in Esophageal Cancer
Home ยป
FDA Panel Votes Against Two Cancer Indications but Backs 4 of 6
Federal advisers this week supported the efforts of pharmaceutical companies in 4 of 6 cases in which these firms are
FDA Panel Votes Against Two Cancer Indications but Backs 4 of 6
Federal advisers this week supported the efforts of pharmaceutical companies in 4 of 6 cases in which these firms are